[ET Net News Agency, 3 January 2022] INNOVENT BIO (01801) fell 4.87% to HK$45.9.
It hits an intra-day low of HK$45.8, and an intra-day high of HK$49.5. The total shares
traded was 376,020, with a value of HK$17.68m. The active buy/sell ratio is 25:75, with
net selling turnover of HK$7.8m. CREDIT SUISSE (HK) SEC accounts for greatest net
responsive buying turnover of HK$1.52m, with volume weighted average price of HK$46.635.
GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of
HK$354,392, with volume weighted average price of HK$46.853.
The Hang Seng Index now fell 67 points, or 0.29% to 23,329; the Hang Seng China
Enterprises Index now fell 38 points, or 0.47% to 8,197; the Hang Seng TECH Index now fell
15 points, or 0.27% to 5,655; with an overall turnover of HK$19.8b.
Basic Information
=================
----------------------------------
Nominal 45.900 % Chg -4.87%
High 49.500 Low 45.800
Shares Tr 376,020 Turnover 17.68m
10-D SMA 48.915 %H.V 71.336
20-D SMA 55.495 VWAP 47.006
50-D SMA 65.926 RSI14 27.912
----------------------------------
Status: Active buy/sell ratio is 25:75, with net selling turnover of HK$7.8m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
INNOVENT BIO (01801) 45.90 -4.87
GENSCRIPT BIO (01548) 33.65 -2.46
ASCLETIS-B (01672) 3.82 +16.11
JUNSHI BIO (01877) 57.70 -0.52
WUXI BIO (02269) 86.85 -6.16
TIGERMED (03347) 94.70 -4.34
BEIGENE (06160) 162.50 +0.93
CANSINOBIO-B (06185) 176.00 -2.33
AKESO-B (09926) 30.85 -9.26
KINTOR PHARMA-B (09939) 13.26 +7.80
-----------------------------------------------
(ed)